Cargando…

Clinical prognosis of optimal medical therapy after percutaneous coronary intervention in patients with coronary heart disease

Detalles Bibliográficos
Autores principales:	Hao, Jing-Yan, Zhang, Jian, Jing, Rui, Liu, Jing-Jing, Di, Cheng-Ye, Lu, Yu-Jie, Gao, Peng, Wang, Ya-Jie, Yang, Rui-Fei, Lin, Wen-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382476/ https://www.ncbi.nlm.nih.gov/pubmed/34387614 http://dx.doi.org/10.1097/CM9.0000000000001720

Ejemplares similares

Percutaneous coronary intervention following Fontan procedure
por: Subahi, Ahmed, et al.
Publicado: (2020)

Effect of Ticagrelor on Coronary Blood Flow and Prognosis in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in Real World
por: Jin, Yan-Yan, et al.
Publicado: (2018)

Extracorporeal Membrane Oxygenation-Assisted Percutaneous Coronary Intervention in Extremely High-Risk Patients
por: Shi, Wen-Jian, et al.
Publicado: (2018)

Safety and efficacy of the Expressman Extension System for complex coronary lesions during percutaneous coronary intervention
por: Ma, Yanzhuo, et al.
Publicado: (2023)

Relationship between dynamic changes of peri-procedure anxiety and short-term prognosis in patients undergoing elective percutaneous coronary intervention for coronary heart disease: A single-center, prospective study
por: Hu, Yao-yao, et al.
Publicado: (2022)

Geographical and socioeconomic disparities in the use of percutaneous coronary intervention in the Philippines
por: Callanta, Maria Llaine J., et al.
Publicado: (2022)

Current trends in optimal medical therapy after PCI and its influence on clinical outcomes in China
por: Zhang, Jian, et al.
Publicado: (2021)

Efficacy and safety of bivalirudin without post-procedure infusion in patients with coronary heart disease during elective percutaneous coronary intervention: a real-world study
por: Wang, Ping, et al.
Publicado: (2022)

Percutaneous Coronary Intervention for a Recent Myocardial Infarction with an Anomalous Right Coronary Artery Arising from the Mid Left Anterior Descending Coronary Artery
por: An, Sung-Gyu, et al.
Publicado: (2016)

Case report: Takotsubo syndrome following percutaneous coronary intervention
por: Lu, Rui, et al.
Publicado: (2023)

An optimal window of platelet reactivity by LTA assay for patients undergoing percutaneous coronary intervention
por: Wang, Jing, et al.
Publicado: (2021)

Effect of Xinyue capsules on patients with coronary heart disease after percutaneous coronary intervention: study protocol for a randomized controlled trial
por: Guo, Ming, et al.
Publicado: (2016)

Cerebral Hemorrhage Complicating Heparin-induced Thrombocytopenia after Percutaneous Coronary Intervention: A Clinical Dilemma of Medical Treatment
por: Qin, Xue, et al.
Publicado: (2015)

Application of adenosine stress echocardiography in the prognosis of acute myocardial infarction following percutaneous coronary interventional therapy
por: REN, LIHUI, et al.
Publicado: (2013)

Establishing an animal model to investigate depression with coronary heart disease
por: Guo, Chun-Xia, et al.
Publicado: (2019)

Effects of renal denervation on cardiac function after percutaneous coronary intervention in patients with acute myocardial infarction()
por: Gao, Jun-Qing, et al.
Publicado: (2023)

Coronary Artery Aneurysm Formation after Drug-Coated Balloon Treatment
por: Huang, Jing, et al.
Publicado: (2018)

Homocysteine is associated with the progression of non-culprit coronary lesions in elderly acute coronary syndrome patients after percutaneous coronary intervention
por: Han, Tian-Wen, et al.
Publicado: (2016)

The optimal timing for non-culprit percutaneous coronary intervention in patients with multivessel coronary artery disease: A pairwise and network meta-analysis of randomized trials
por: Feng, Yujia, et al.
Publicado: (2022)

Effects of PCSK9 Inhibition on Coronary Atherosclerosis Regression of Nontarget Lesions after Primary Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
por: Li, Yongjun, et al.
Publicado: (2022)

Lessons from transulnar access for repeat percutaneous coronary intervention after radial artery occlusion
por: Bi, Xi-Le, et al.
Publicado: (2020)

Association of Serum miR-186-5p With the Prognosis of Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention
por: Li, Zhuoling, et al.
Publicado: (2019)

Triple versus dual antiplatelet therapy for coronary heart disease patients undergoing percutaneous coronary intervention: A meta-analysis
por: ZHOU, HONG, et al.
Publicado: (2013)

Analysis of thrombelastogram-guided medication in patients with coronary heart disease after percutaneous coronary intervention
por: Li, Yingbo, et al.
Publicado: (2019)

Risk factors for repeat percutaneous coronary intervention in young patients (≤45 years of age) with acute coronary syndrome
por: Han, Tianwen, et al.
Publicado: (2019)

Association of hemoglobin glycation index with prognosis of coronary artery disease after percutaneous coronary intervention: A retrospective cohort study
por: Cheng, Meng-Die, et al.
Publicado: (2023)

Obstructive Sleep Apnea Affecting Platelet Reactivity in Patients Undergoing Percutaneous Coronary Intervention
por: Jiang, Xiao-Min, et al.
Publicado: (2018)

Long-term outcomes of percutaneous coronary intervention for in-stent chronic total occlusion
por: Gong, Ming-Lian, et al.
Publicado: (2021)

Prognosis and Medical Cost of Measuring Fractional Flow Reserve in Percutaneous Coronary Intervention
por: Hong, David, et al.
Publicado: (2022)

Clinical evaluation of high intensity interval training exercise in coronary heart disease patients after percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Cheng, Xiaohui, et al.
Publicado: (2021)

Percutaneous Coronary Intervention Is Not Superior to Optimal Medical Therapy in Chronic Coronary Syndrome: A Meta-Analysis
por: Bytyçi, Ibadete, et al.
Publicado: (2023)

Optimal medical therapy after percutaneous coronary intervention in very elderly patients with coronary artery disease()
por: Nakamura, Takamitsu, et al.
Publicado: (2022)

Prognostic value of quantitative flow ratio in patients with coronary heart disease after percutaneous coronary intervention therapy: a meta-analysis
por: Chen, Huaigang, et al.
Publicado: (2023)

Effects of nicorandil on systemic inflammation and oxidative stress induced by percutaneous coronary intervention in patients with coronary heart disease
por: Zong, Yulong, et al.
Publicado: (2021)

Bivalirudin in patients undergoing percutaneous coronary intervention and independent predictors of postoperative adverse events in these patients: A real world retrospective study
por: Hu, Yue-cheng, et al.
Publicado: (2021)

Effect of indobufen vs. aspirin on platelet accumulation in patients with stable coronary heart disease after percutaneous coronary intervention: An open-label crossover study
por: Shi, Qiu-Ping, et al.
Publicado: (2022)

Nutritional Risk Index Improves the GRACE Score Prediction of Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Ma, Xiao-Teng, et al.
Publicado: (2021)

Prognostic Nutritional Index as a Novel Predictor of Long-Term Prognosis in Patients with Coronary Artery Disease After Percutaneous Coronary Intervention
por: Liu, Tian-Ding, et al.
Publicado: (2022)

Relationship between lncRNA-Ang362 and prognosis of patients with coronary heart disease after percutaneous coronary intervention
por: Wang, Hui, et al.
Publicado: (2020)

Prognosis of coronary heart disease after percutaneous coronary intervention: a bibliometric analysis over the period 2004–2022
por: Tao, Shiyi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cbu7c4kinpjr5288uas0gf219m